Asia Pacific Pneumonia Vaccines Market 2019-2025)
The Asia Pacific Pneumonia Vaccines Market would witness market growth of 6.2% CAGR during the forecast period (2019–2025).
Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, virus, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Pneumonia results in inflammation in the air sacs (known as alveoli) of the lungs thereby filling the alveoli with fluid (pus cells), thus causing breathing problems. Pneumococcal disease is common in young children, but older adults are at the greatest risk of serious pneumococcal infections and even death. Pneumonia vaccines are primarily administered to children less than 2-years old and adults aged 65 years and older. This vaccine helps individuals provide immunization against 13 types of pneumococcal bacteria that cause infection in the lungs.
The key factors that drive the growth of the pneumonia vaccine market include an increase in the prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and introduction of novel pneumococcal vaccines such as PCV10. However, longer timelines required for pneumonia vaccine production and high costs associated with the development of such vaccines restrain the market growth.
Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. and MERCK & CO., Inc.
Scope of the Study
Market Segmentation:
By Vaccine Type
Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, virus, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Pneumonia results in inflammation in the air sacs (known as alveoli) of the lungs thereby filling the alveoli with fluid (pus cells), thus causing breathing problems. Pneumococcal disease is common in young children, but older adults are at the greatest risk of serious pneumococcal infections and even death. Pneumonia vaccines are primarily administered to children less than 2-years old and adults aged 65 years and older. This vaccine helps individuals provide immunization against 13 types of pneumococcal bacteria that cause infection in the lungs.
The key factors that drive the growth of the pneumonia vaccine market include an increase in the prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and introduction of novel pneumococcal vaccines such as PCV10. However, longer timelines required for pneumonia vaccine production and high costs associated with the development of such vaccines restrain the market growth.
Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. and MERCK & CO., Inc.
Scope of the Study
Market Segmentation:
By Vaccine Type
- Pneumococcal conjugate vaccine (PCV)
- Pneumococcal polysaccharide vaccine (PPSV/PPV)
- Prevnar 13
- Synflorix
- Pneumovax23
- Public sector
- Private sector
- Distribution partner companies
- Non-governmental Organizations (NGO)
- Government Authorities
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- Glaxosmithkline Plc. (GSK)
- LG Corporation
- Panacea Biotec Limited
- Pfizer, Inc.
- Pnuvax Incorporated
- Poonawalla Investments & Industries Pvt. Ltd.
- Shenzhen Kangtai Biological Products Co., Ltd.
- SK Holdings Co., Ltd.
- Walvax Biotechnology Co., Ltd.
- Merck & Co., Inc.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Pneumonia Vaccines Market, by Vaccine Type
1.4.2 Asia Pacific Pneumonia Vaccines Market, by Product Type
1.4.3 Asia Pacific Pneumonia Vaccines Market, by Sector
1.4.4 Asia Pacific Pneumonia Vaccines Market, by Distribution Channel
1.4.5 Asia Pacific Pneumonia Vaccines Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE
3.1 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 Asia Pacific Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
CHAPTER 4. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE
4.1 Asia Pacific Prevnar 13 Market by Region
4.2 Asia Pacific Synflorix Market by Region
4.3 Asia Pacific Pneumovax 23 Market by Region
CHAPTER 5. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR
5.1 Asia Pacific Private sector Market by Region
5.2 Asia Pacific Public sector Market by Region
CHAPTER 6. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL
6.1 Asia Pacific Distribution Partner Companies Market by Region
6.2 Asia Pacific Non-Governmental Organizations (NGO) Market by Region
6.3 Asia Pacific Government Authorities Market by Region
CHAPTER 7. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION
7.1 China Pneumonia Vaccines Market
7.1.1 China Pneumonia Vaccines Market by Type
7.1.2 China Pneumonia Vaccines Market by Product Type
7.1.3 China Pneumonia Vaccines Market by Sector
7.1.4 China Pneumonia Vaccines Market by Distribution Channel
7.2 Japan Pneumonia Vaccines Market
7.2.1 Japan Pneumonia Vaccines Market by Type
7.2.2 Japan Pneumonia Vaccines Market by Product Type
7.2.3 Japan Pneumonia Vaccines Market by Sector
7.2.4 Japan Pneumonia Vaccines Market by Distribution Channel
7.3 India Pneumonia Vaccines Market
7.3.1 India Pneumonia Vaccines Market by Type
7.3.2 India Pneumonia Vaccines Market by Product Type
7.3.3 India Pneumonia Vaccines Market by Sector
7.3.4 India Pneumonia Vaccines Market by Distribution Channel
7.4 South Korea Pneumonia Vaccines Market
7.4.1 South Korea Pneumonia Vaccines Market by Type
7.4.2 South Korea Pneumonia Vaccines Market by Product Type
7.4.3 South Korea Pneumonia Vaccines Market by Sector
7.4.4 South Korea Pneumonia Vaccines Market by Distribution Channel
7.5 Singapore Pneumonia Vaccines Market
7.5.1 Singapore Pneumonia Vaccines Market by Type
7.5.2 Singapore Pneumonia Vaccines Market by Product Type
7.5.3 Singapore Pneumonia Vaccines Market by Sector
7.5.4 Singapore Pneumonia Vaccines Market by Distribution Channel
7.6 Malaysia Pneumonia Vaccines Market
7.6.1 Malaysia Pneumonia Vaccines Market by Type
7.6.2 Malaysia Pneumonia Vaccines Market by Product Type
7.6.3 Malaysia Pneumonia Vaccines Market by Sector
7.6.4 Malaysia Pneumonia Vaccines Market by Distribution Channel
7.7 Rest of Asia Pacific Pneumonia Vaccines Market
7.7.1 Rest of Asia Pacific Pneumonia Vaccines Market by Type
7.7.2 Rest of Asia Pacific Pneumonia Vaccines Market by Product Type
7.7.3 Rest of Asia Pacific Pneumonia Vaccines Market by Sector
7.7.4 Rest of Asia Pacific Pneumonia Vaccines Market by Distribution Channel
CHAPTER 8. COMPANY PROFILES
8.1 GLAXOSMITHKLINE PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Collaboration, partnerships and agreements:
8.1.1.2 Expansion:
8.1.2 SWOT Analysis
8.2 LG Corporation (LG Chemicals Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Panacea Biotec Limited
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Collaboration, partnerships and agreements:
8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Collaboration, partnerships and agreements:
8.4.5.2 Product launch:
8.4.6 SWOT Analysis
8.5 PnuVax Incorporated
8.5.1 Company Overview
8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
8.6.1 Company Overview
8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
8.7.1 Company Overview
8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
8.8.1 Company overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Walvax Biotechnology Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Product launch:
8.1 Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Collaboration, partnerships and agreements:
8.10.5.2 Product launch:
8.10.6 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Pneumonia Vaccines Market, by Vaccine Type
1.4.2 Asia Pacific Pneumonia Vaccines Market, by Product Type
1.4.3 Asia Pacific Pneumonia Vaccines Market, by Sector
1.4.4 Asia Pacific Pneumonia Vaccines Market, by Distribution Channel
1.4.5 Asia Pacific Pneumonia Vaccines Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE
3.1 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 Asia Pacific Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
CHAPTER 4. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE
4.1 Asia Pacific Prevnar 13 Market by Region
4.2 Asia Pacific Synflorix Market by Region
4.3 Asia Pacific Pneumovax 23 Market by Region
CHAPTER 5. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR
5.1 Asia Pacific Private sector Market by Region
5.2 Asia Pacific Public sector Market by Region
CHAPTER 6. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL
6.1 Asia Pacific Distribution Partner Companies Market by Region
6.2 Asia Pacific Non-Governmental Organizations (NGO) Market by Region
6.3 Asia Pacific Government Authorities Market by Region
CHAPTER 7. ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION
7.1 China Pneumonia Vaccines Market
7.1.1 China Pneumonia Vaccines Market by Type
7.1.2 China Pneumonia Vaccines Market by Product Type
7.1.3 China Pneumonia Vaccines Market by Sector
7.1.4 China Pneumonia Vaccines Market by Distribution Channel
7.2 Japan Pneumonia Vaccines Market
7.2.1 Japan Pneumonia Vaccines Market by Type
7.2.2 Japan Pneumonia Vaccines Market by Product Type
7.2.3 Japan Pneumonia Vaccines Market by Sector
7.2.4 Japan Pneumonia Vaccines Market by Distribution Channel
7.3 India Pneumonia Vaccines Market
7.3.1 India Pneumonia Vaccines Market by Type
7.3.2 India Pneumonia Vaccines Market by Product Type
7.3.3 India Pneumonia Vaccines Market by Sector
7.3.4 India Pneumonia Vaccines Market by Distribution Channel
7.4 South Korea Pneumonia Vaccines Market
7.4.1 South Korea Pneumonia Vaccines Market by Type
7.4.2 South Korea Pneumonia Vaccines Market by Product Type
7.4.3 South Korea Pneumonia Vaccines Market by Sector
7.4.4 South Korea Pneumonia Vaccines Market by Distribution Channel
7.5 Singapore Pneumonia Vaccines Market
7.5.1 Singapore Pneumonia Vaccines Market by Type
7.5.2 Singapore Pneumonia Vaccines Market by Product Type
7.5.3 Singapore Pneumonia Vaccines Market by Sector
7.5.4 Singapore Pneumonia Vaccines Market by Distribution Channel
7.6 Malaysia Pneumonia Vaccines Market
7.6.1 Malaysia Pneumonia Vaccines Market by Type
7.6.2 Malaysia Pneumonia Vaccines Market by Product Type
7.6.3 Malaysia Pneumonia Vaccines Market by Sector
7.6.4 Malaysia Pneumonia Vaccines Market by Distribution Channel
7.7 Rest of Asia Pacific Pneumonia Vaccines Market
7.7.1 Rest of Asia Pacific Pneumonia Vaccines Market by Type
7.7.2 Rest of Asia Pacific Pneumonia Vaccines Market by Product Type
7.7.3 Rest of Asia Pacific Pneumonia Vaccines Market by Sector
7.7.4 Rest of Asia Pacific Pneumonia Vaccines Market by Distribution Channel
CHAPTER 8. COMPANY PROFILES
8.1 GLAXOSMITHKLINE PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Collaboration, partnerships and agreements:
8.1.1.2 Expansion:
8.1.2 SWOT Analysis
8.2 LG Corporation (LG Chemicals Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Panacea Biotec Limited
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Collaboration, partnerships and agreements:
8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Collaboration, partnerships and agreements:
8.4.5.2 Product launch:
8.4.6 SWOT Analysis
8.5 PnuVax Incorporated
8.5.1 Company Overview
8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
8.6.1 Company Overview
8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
8.7.1 Company Overview
8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
8.8.1 Company overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Walvax Biotechnology Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Product launch:
8.1 Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Collaboration, partnerships and agreements:
8.10.5.2 Product launch:
8.10.6 SWOT Analysis
LIST OF TABLES
TABLE 1 ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 CHINA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 34 CHINA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 35 CHINA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 36 CHINA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 37 CHINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 38 CHINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 39 CHINA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 40 CHINA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 41 CHINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 CHINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 JAPAN PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 44 JAPAN PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 45 JAPAN PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 46 JAPAN PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 47 JAPAN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 48 JAPAN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 49 JAPAN PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 50 JAPAN PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 51 JAPAN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 JAPAN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 INDIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 54 INDIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 55 INDIA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 INDIA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 INDIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 58 INDIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 59 INDIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 60 INDIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 61 INDIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 62 INDIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 63 SOUTH KOREA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 64 SOUTH KOREA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 65 SOUTH KOREA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 66 SOUTH KOREA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 67 SOUTH KOREA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 68 SOUTH KOREA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 69 SOUTH KOREA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 70 SOUTH KOREA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 71 SOUTH KOREA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 72 SOUTH KOREA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 73 SINGAPORE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 74 SINGAPORE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 75 SINGAPORE PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 76 SINGAPORE PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 77 SINGAPORE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 78 SINGAPORE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 79 SINGAPORE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 80 SINGAPORE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 81 SINGAPORE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 SINGAPORE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 MALAYSIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 84 MALAYSIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 85 MALAYSIA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 86 MALAYSIA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 87 MALAYSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 88 MALAYSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 89 MALAYSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 90 MALAYSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 91 MALAYSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 92 MALAYSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 93 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 94 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 95 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 96 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 97 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 98 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 99 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 100 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 101 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 102 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 103 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 104 KEY INFORMATION – LG CORPORATION
TABLE 105 KEY INFORMATION – PANACEA BIOTEC LIMITED
TABLE 106 KEY INFORMATION – PFIZER, INC.
TABLE 107 KEY INFORMATION – PNUVAX INCORPORATED
TABLE 108 KEY INFORMATION – POONAWALLA INVESTMENTS & INDUSTRIES PVT. LTD.
TABLE 109 KEY INFORMATION – SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
TABLE 110 KEY INFORMATION – SK HOLDINGS CO., LTD.
TABLE 111 KEY INFORMATION – WALVAX BIOTECHNOLOGY CO., LTD.
TABLE 112 KEY INFORMATION - MERCK & CO., INC.
TABLE 1 ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 CHINA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 34 CHINA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 35 CHINA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 36 CHINA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 37 CHINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 38 CHINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 39 CHINA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 40 CHINA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 41 CHINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 CHINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 JAPAN PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 44 JAPAN PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 45 JAPAN PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 46 JAPAN PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 47 JAPAN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 48 JAPAN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 49 JAPAN PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 50 JAPAN PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 51 JAPAN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 JAPAN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 INDIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 54 INDIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 55 INDIA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 INDIA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 INDIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 58 INDIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 59 INDIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 60 INDIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 61 INDIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 62 INDIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 63 SOUTH KOREA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 64 SOUTH KOREA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 65 SOUTH KOREA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 66 SOUTH KOREA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 67 SOUTH KOREA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 68 SOUTH KOREA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 69 SOUTH KOREA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 70 SOUTH KOREA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 71 SOUTH KOREA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 72 SOUTH KOREA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 73 SINGAPORE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 74 SINGAPORE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 75 SINGAPORE PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 76 SINGAPORE PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 77 SINGAPORE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 78 SINGAPORE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 79 SINGAPORE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 80 SINGAPORE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 81 SINGAPORE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 SINGAPORE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 MALAYSIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 84 MALAYSIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 85 MALAYSIA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 86 MALAYSIA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 87 MALAYSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 88 MALAYSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 89 MALAYSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 90 MALAYSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 91 MALAYSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 92 MALAYSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 93 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 94 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 95 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 96 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 97 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 98 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 99 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 100 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 101 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 102 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 103 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 104 KEY INFORMATION – LG CORPORATION
TABLE 105 KEY INFORMATION – PANACEA BIOTEC LIMITED
TABLE 106 KEY INFORMATION – PFIZER, INC.
TABLE 107 KEY INFORMATION – PNUVAX INCORPORATED
TABLE 108 KEY INFORMATION – POONAWALLA INVESTMENTS & INDUSTRIES PVT. LTD.
TABLE 109 KEY INFORMATION – SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
TABLE 110 KEY INFORMATION – SK HOLDINGS CO., LTD.
TABLE 111 KEY INFORMATION – WALVAX BIOTECHNOLOGY CO., LTD.
TABLE 112 KEY INFORMATION - MERCK & CO., INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
